Path Ex

Houston, TX · Founded 2017 · Privately Held (backing)

Developer of an extracorporeal blood-cleansing device designed for the diagnosis and treatment of sepsis. Path Ex is based in Houston, TX and was founded in 2017. It was valued at $31 million at its seed round in Apr 2025, the last priced event on record. It has raised $12.5 million across 1 recorded round; the latest was an $8.2 million early-stage round in Apr 2025.

PMV mark · valuation
$31.0M
Oct 2026
Priced at
its seed round
Apr 2025
Total raised
$12.5M
Last round
Early Stage VC
Apr 2025
How much has Path Ex raised?
$12.5Macross 1 recorded rounds · Apr 2025 – Apr 2025

Most recently, Path Ex raised $8.2M in its Early Stage VC (Apr 2025).

Free account
More of Path Ex with a free account
  • ·The complete investor list: 18 names
  • ·Watch Path Ex: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Path Ex round by round

1 rounds
Apr 2025Early Stage VC$8.2MSEC filing▮
14 investors participated

How much has Path Ex raised?

Path Ex has raised $12.5 million in total; 1 of its rounds is on record. The largest on record was an $8.2 million early-stage round in Apr 2025.

Path Ex has filed 1 Form D with the SEC, most recently in May 2025 ($8.2 million sold to 14 investors).

Path Ex investors

18 investors are on record for Path Ex, including US National Science Foundation, MassChallenge, MedTech Innovator and Texas Medical Center. By type, the record holds 5 venture capital firms. The early-stage round in Apr 2025 drew 14 investors.

For fundraisers
Raising for a company like Path Ex?

18 investors have backed Path Ex.

See all 18 investors →

Frequently asked about Path Ex

How much has Path Ex raised?
Path Ex has raised $12.5M in total across 1 recorded funding rounds.
When was Path Ex's last funding round?
Path Ex's most recent recorded round was Early Stage VC in Apr 2025, raising $8.2M.